Intellectual Property

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     China

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     Japan

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     United States

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     Europe

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     Australia

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     Australia

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     Canada

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     Switzerland

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     Germany

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     France

Oligonucleotides for mRNA regulation              PCT/DK2007/050174     United Kingdom

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     Canada

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     Switzerland

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     Japan

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     Australia

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     Europe

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     United States

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     United States

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     Switzerland

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     Germany

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     France

Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141     United Kingdom

Bivalent antisense oligonucleotides              PCT/EP2011/054545              United States

Bivalent antisense oligonucleotides              PCT/EP2011/054545              Europe

Bivalent antisense oligonucleotides              PCT/EP2011/054545              Switzerland

Bivalent antisense oligonucleotides              PCT/EP2011/054545              Germany

Bivalent antisense oligonucleotides              PCT/EP2011/054545              France

Bivalent antisense oligonucleotides              PCT/EP2011/054545              United Kingdom

Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447     Europe

Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447     United States

Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447    United States

Oligomers with improved off-target profile              PCT/2013/050308    Australia

Oligomers with improved off-target profile              PCT/2013/050308    Canada

Oligomers with improved off-target profile              PCT/2013/050308    Europe

Oligomers with improved off-target profile              PCT/2013/050308    India

Oligomers with improved off-target profile                                                    China

Oligomers with improved off-target profile              PCT/2013/050308    Japan

Oligomers with improved off-target profile              PCT/2013/050308  United States

Methods for treating tumours                  15/750092                           USA

Methods for treating tumours                                              Europe

Methods for treating tumours                                              China

Methods for treating tumours    Prov        AU2015903130 Australia

Methods for treating tumours    PCT              PCT/AU2016/050712    WO/2017/020094                            Australia

Modulation of RNA activity and Vascular permeability                            14/433150         USA

Modulation of RNA activity and Vascular permeability                            2015-534880     Japan

Modulation of RNA activity and Vascular permeability                            13843154.9       Europe

Modulation of RNA activity and Vascular permeability                            201380061417.2            China

Modulation of RNA activity and Vascular permeability                            3707/DELNP/2015          India

Modulation of RNA activity and Vascular permeability                            2886745                          Canada

Modulation of RNA activity and Vascular permeability                            2013327393                    Australia

Modulation of RNA activity and Vascular permeability                            Prov 2012904297           Australia

Modulation of RNA activity and Vascular permeability                            Prov  201204365            Australia

Modulation of RNA activity and Vascular permeability                            PCT/AU2013/001129      WO2014/053014            Australia

Therapeutic and diagnostic molecules                   9320755                          USA

Therapeutic and diagnostic molecules                   10782840.2                     Europe

Therapeutic and diagnostic molecules                   2010256284                    Australia

Therapeutic and diagnostic molecules                   16/056393                       USA

INTELLECTUAL PROPERTY